Long-term efficacy and safety of zoledronic acid in patients with bone metastases from renal cell carcinoma

被引：0
|
作者：
Lipton, A
Seaman, J
Zheng, M
机构：
[1] Milton S Hershey Med Ctr, Hershey, PA USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
BONE | 2004年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [1] LONG-TERM SAFETY OF ZOLEDRONIC ACID FOR BREAST CANCER WITH BONE METASTASES
    Taira, Shinichiro
    Takahashi, Shunji
    Ito, Yoshinori
    Tokudome, Nahomi
    Tsutsumi, Chizuko
    Kobayashi, Kokoro
    Fukuda, Takayo
    Asai, Hiroaki
    Oto, Masahumi
    Ito, Mayuko
    Hatake, Kiyohiko
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [2] Long-term safety of zoledronic acid for the treatment of patients with breast cancer and bone metastases
    Lipton, A.
    Dewar, R.
    Conte, R.
    Zheng, M.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 142 - 142
  • [3] Efficacy of zoledronic acid in the treatment of bone metastases secondary to renal cell carcinoma
    Schulman, CC
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (05) : 40 - 45
  • [4] Significance of zoledronic acid on survival in patients with bone metastases from renal cell carcinoma
    Fujii, Yasuhisa
    Yasuda, Yosuke
    Yuasa, Takeshi
    Sukegawa, Gen
    Kitsukawa, Shinichi
    Urakami, Shinji
    Yamamoto, Shinya
    Yonese, Junji
    Takahashi, Shunji
    Fukui, Iwao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors
    Tanvetyanon, T
    Hines, E
    [J]. CANCER, 2005, 103 (08) : 1756 - 1757
  • [6] Significance of zoledronic acid on survival in patients with bone metastases from renal cell carcinoma
    Yasuda, Yosuke
    Fujii, Yasuhisa
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Urakami, Shinji
    Yamamoto, Shinya
    Yonese, Junji
    Takahashi, Shunji
    Fukui, Iwao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer
    Saad, Fred
    Eastham, James A.
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (03) : S38 - S44
  • [8] Zoledronic acid has long-term efficacy in reducing skeletal complications in patients with bone metastases from breast cancer
    Coleman, R.
    Rosen, L.
    Zheng, M.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 127 - 128
  • [9] Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors - Author reply
    Rosen, LS
    [J]. CANCER, 2005, 103 (08) : 1757 - 1758
  • [10] Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma
    Yasuda, Yosuke
    Fujii, Yasuhisa
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Urakami, Shinji
    Yamamoto, Shinya
    Yonese, Junji
    Takahashi, Shunji
    Fukui, Iwao
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 877 - 883
12345